(Q30366863)

21 June 2017

title

AIDS vaccine: efficacy, safety and ethics. (English)

1 reference

21 June 2017

0 references

3

Sanja Glisic

1 reference

21 June 2017

2

Nevena Veljkovic

0 references

Veljko Veljkovic

series ordinal

1

object named as

Veljko Veljkovic

1 reference

21 June 2017

Nevena Veljkovic

2

1 reference

21 June 2017

Mae-Wan Ho

series ordinal

4

1 reference

21 June 2017

language of work or name

English

0 references

publication date

17 December 2007

1 reference

21 June 2017

1 reference

21 June 2017

volume

26

1 reference

21 June 2017

issue

24

1 reference

21 June 2017

page(s)

3072-3077

1 reference

Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

7 January 2021

HIV vaccination dilemma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

What can be achieved with an HIV vaccine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

HIV: to vaccinate or not to vaccinate?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

An HIV vaccine--evolving concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Protein and DNA-sequence homologies between the V3-loop of human immunodeficiency virus type I envelope protein gp120 and immunoglobulin variable regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Identification of immunoglobulin recombinant elements in human immunodeficiency virus type 1 envelope gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Immunoglobulin-like domain of HIV-1 envelope glycoprotein gp120 encodes putative internal image of some common human proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Further evidence for the relationship of HIV-1 gp120 V3 loops with Ig superfamily members: similarity with the putative CDR3 region of T-cell receptor delta-chains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Molecular makeup of HIV-1 envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

HIV and idiotypic T-cell regulation: another view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Does the HIV-1 manipulate immune network via gp120 immunoglobulin-like domain involving V3 loop?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

HIV-1 gp120 and immune network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Anti-V3 and anti-IgG antibodies of healthy individuals share complementarity structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Human immunodeficiency virus V3 peptide-reactive antibodies are present in normal HIV-negative sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Deceptive imprinting in the immune response against HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Avoiding deceptive imprinting of the immune response to HIV-1 infection in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Longitudinal population analysis of dual infection with recombination in two strains of HIV type 1 subtype B in an individual from a Phase 3 HIV vaccine efficacy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

High incidence of unusual cysteine variants in gp120 envelope proteins from early HIV type 1 infections from a Phase 3 vaccine efficacy trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Identification of an active Chi recombinational hot spot within the HIV-1 envelope gene: consequences for development of AIDS vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Recombination property of the HIV-1 gp120 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

Does VaxGen hide the breakthrough infections?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

AIDSVAX results: an important open question

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.061

10.1016/J.VACCINE.2007.11.061

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference